Stock Comparison

HITI vs LLY

High Tide Inc vs Eli Lilly and Co

The Verdict

HITI takes this one.

Winner

HITI

High Tide Inc

7.5

out of 10

Solid Pick

LLY

Eli Lilly and Co

0.5

out of 10

Distressed

Head-to-Head

$297M

Market Cap

$965.0B

-6.8

P/E Ratio

52.6

-7.4%

Profit Margin

N/A

-40.9%

Return on Equity

N/A

1.3

Debt-to-Equity

N/A

Aggressive

Overall Risk

Moderate

7.5

DVR Score

0.5

The Deep Dive

HITI7.5/10

Score Change Explanation: The previous analysis on 2026-04-10 assigned a score of 8.4/10 based on robust Q1 fiscal 2026 results, highlighting strong revenue growth, Adjusted EBITDA, and positive free cash flow. However, the most recent Q2 fiscal 2026 earnings (reported March 17, 2026) revealed a material deterioration. Revenue of $130.88 million significantly missed consensus estimates of $173.80 ...

Full HITI Analysis

LLY0.5/10

Eli Lilly remains a pharmaceutical powerhouse with exceptional market leadership, especially driven by its GLP-1 agonist franchise (Mounjaro/Zepbound). The company possesses a robust R&D pipeline and substantial competitive advantages through intellectual property and scale. While LLY offers strong long-term growth and stability, its current market capitalization exceeding $1 trillion makes achiev...

Full LLY Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.